Prateek Agrawal of Motilal Oswal Asset Management Company has shared his latest sectoral outlook, highlighting opportunities in banking, digital businesses and select pharmaceutical companies while remaining cautious on FMCG, large-cap IT and private sector banks. His comments reflect a selective investment approach focused on sectors with visible earnings momentum rather than broad market exposure.

According to Prateek Agrawal, companies in the Banking, Financial Services and Insurance (BFSI) sector have reported a strong first-quarter performance. Key observations include:

• Healthy Q1 earnings across several BFSI players.
• Financial companies continue to demonstrate resilience despite evolving economic conditions.
• Earnings momentum remains supportive for the sector.

Strong quarterly performance generally helps reinforce investor confidence and supports long-term business fundamentals.

Stay Updated With Expert Market Views

👉 Latest Nifty Tips

👉 Latest BankNifty Tips

Prateek Agrawal indicated that the portfolio is not invested in large-cap IT companies or private sector banks. He also noted that:

• IT sector margins currently reflect the impact of the sharp depreciation in the Indian rupee.
• The investment team is adopting a selective approach rather than broad exposure to these sectors.

Portfolio positioning often reflects expectations about future risk-adjusted returns rather than the current operating performance of individual companies.

The fund manager continues to see favourable trends in digital businesses. Key themes include:

• Value migration continues to support digital-first companies.
• Digital adoption remains a long-term structural growth driver.
• Technology-enabled businesses may continue benefiting from changing consumer behaviour and enterprise digitisation.

Structural themes often create long-term investment opportunities beyond short-term market fluctuations.

Motilal Oswal AMC remains constructive on pharmaceutical companies associated with GLP-1 therapies. Key highlights include:

• Focus remains on Semaglutide-related opportunities.
• GLP-1 ecosystem players are expected to report strong earnings over the near-to-medium term.
• The fund manager expects better growth prospects in this segment than in several traditional defensive sectors.

In contrast, the outlook for the FMCG sector remains cautious, with no meaningful growth expected in the near term according to the fund manager.

Investor Takeaway

Indian-Share-Tips.com Nifty Expert Gulshan Khera, CFP®, who is also a SEBI Registered Investment Adviser, observes that sector rotation continues to play an important role in portfolio performance. While Motilal Oswal AMC currently favours BFSI, digital businesses and GLP-1-linked pharmaceutical companies, investors should remember that sector preferences can change as valuations, earnings and macroeconomic conditions evolve. Diversification and disciplined stock selection remain essential for long-term wealth creation.

Read more expert market commentary and investment insights at Indian-Share-Tips.com.

Written by Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.

Disclaimer: This article is intended solely for educational and informational purposes and summarizes the views expressed by a market participant. These views do not constitute investment advice or a recommendation to buy or sell any security. Investors should conduct independent research or consult a SEBI Registered Investment Adviser before making investment decisions.